These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37726739)

  • 21. Expression of complement system components during aging and amyloid deposition in APP transgenic mice.
    Reichwald J; Danner S; Wiederhold KH; Staufenbiel M
    J Neuroinflammation; 2009 Nov; 6():35. PubMed ID: 19917141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut Microbiome Alterations Precede Cerebral Amyloidosis and Microglial Pathology in a Mouse Model of Alzheimer's Disease.
    Chen Y; Fang L; Chen S; Zhou H; Fan Y; Lin L; Li J; Xu J; Chen Y; Ma Y; Chen Y
    Biomed Res Int; 2020; 2020():8456596. PubMed ID: 32596386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C5aR1 signaling promotes region and age dependent synaptic pruning in models of Alzheimer's Disease.
    Gomez-Arboledas A; Fonseca MI; Kramar E; Chu SH; Schartz N; Selvan P; Wood MA; Tenner AJ
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-β neurotoxicity.
    Benoit ME; Hernandez MX; Dinh ML; Benavente F; Vasquez O; Tenner AJ
    J Biol Chem; 2013 Jan; 288(1):654-65. PubMed ID: 23150673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer's disease animal model.
    Kim MS; Kim Y; Choi H; Kim W; Park S; Lee D; Kim DK; Kim HJ; Choi H; Hyun DW; Lee JY; Choi EY; Lee DS; Bae JW; Mook-Jung I
    Gut; 2020 Feb; 69(2):283-294. PubMed ID: 31471351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
    Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
    Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human gut microbiota Agathobaculum butyriciproducens improves cognitive impairment in LPS-induced and APP/PS1 mouse models of Alzheimer's disease.
    Go J; Chang DH; Ryu YK; Park HY; Lee IB; Noh JR; Hwang DY; Kim BC; Kim KS; Lee CH
    Nutr Res; 2021 Feb; 86():96-108. PubMed ID: 33551257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort.
    Liu P; Wu L; Peng G; Han Y; Tang R; Ge J; Zhang L; Jia L; Yue S; Zhou K; Li L; Luo B; Wang B
    Brain Behav Immun; 2019 Aug; 80():633-643. PubMed ID: 31063846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exogenous lipase administration alters gut microbiota composition and ameliorates Alzheimer's disease-like pathology in APP/PS1 mice.
    Menden A; Hall D; Hahn-Townsend C; Broedlow CA; Joshi U; Pearson A; Crawford F; Evans JE; Klatt N; Crynen S; Mullan M; Ait-Ghezala G
    Sci Rep; 2022 Mar; 12(1):4797. PubMed ID: 35314754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease amyloid-β pathology in the lens of the eye.
    Moncaster JA; Moir RD; Burton MA; Chadwick O; Minaeva O; Alvarez VE; Ericsson M; Clark JI; McKee AC; Tanzi RE; Goldstein LE
    Exp Eye Res; 2022 Aug; 221():108974. PubMed ID: 35202705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement and microglia mediate early synapse loss in Alzheimer mouse models.
    Hong S; Beja-Glasser VF; Nfonoyim BM; Frouin A; Li S; Ramakrishnan S; Merry KM; Shi Q; Rosenthal A; Barres BA; Lemere CA; Selkoe DJ; Stevens B
    Science; 2016 May; 352(6286):712-716. PubMed ID: 27033548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease.
    Fonseca MI; Ager RR; Chu SH; Yazan O; Sanderson SD; LaFerla FM; Taylor SM; Woodruff TM; Tenner AJ
    J Immunol; 2009 Jul; 183(2):1375-83. PubMed ID: 19561098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain.
    Fonseca MI; Chu SH; Hernandez MX; Fang MJ; Modarresi L; Selvan P; MacGregor GR; Tenner AJ
    J Neuroinflammation; 2017 Mar; 14(1):48. PubMed ID: 28264694
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Tran TTT; Corsini S; Kellingray L; Hegarty C; Le Gall G; Narbad A; Müller M; Tejera N; O'Toole PW; Minihane AM; Vauzour D
    FASEB J; 2019 Jul; 33(7):8221-8231. PubMed ID: 30958695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement C5a Receptor 1 Exacerbates the Pathophysiology of
    Herrmann JB; Muenstermann M; Strobel L; Schubert-Unkmeir A; Woodruff TM; Gray-Owen SD; Klos A; Johswich KO
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta.
    Hernandez MX; Namiranian P; Nguyen E; Fonseca MI; Tenner AJ
    ASN Neuro; 2017 Feb; 9(1):1759091416687871. PubMed ID: 28078911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut Microbiota Composition and Epigenetic Molecular Changes Connected to the Pathogenesis of Alzheimer's Disease.
    Nagu P; Parashar A; Behl T; Mehta V
    J Mol Neurosci; 2021 Jul; 71(7):1436-1455. PubMed ID: 33829390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
    Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
    J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State.
    Shen L; Liu L; Ji HF
    J Alzheimers Dis; 2017; 56(1):385-390. PubMed ID: 27911317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.